Endo USA, Inc. recalls Everolimus tablets 5mg
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
- Products
-
- Everolimus tablets 5mg
- Company
- Endo USA, Inc.
- Where it was sold
-
Nationwide within the United States
Nationwide
- Units affected
- 1,041 cartons
- About this recall
- Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977, NDC 49884-125-91